Lipid-lowering properties of protein-rich mucuna product

被引:0
|
作者
Ngatchic J.T.M. [1 ]
Njintang N.Y. [2 ]
Bernard C. [3 ]
Oben J. [4 ]
Mbofung C.M. [1 ]
机构
[1] Department of Food Science and Nutrition, National School of Agro-industrial Science, P.O. Box 455, Ngaoundere
[2] Department of Biological Sciences, Faculty of Sciences, University of Ngaoundere, P.O. Box 454, Ngaoundere
[3] Industrial school of Biology, EBInnov Laboratory, 32 boulevard du port, 95094 Cergy, Pontoise Cedex
[4] Department of Biochemistry, Faculty of Sciences, University of Yaounde, P.O. Box 812, Yaounde
关键词
Cholesterol; Oxidative stress; Protein-rich mucuna product; Steatosis; Triglycerides;
D O I
10.1186/s41110-016-0003-0
中图分类号
学科分类号
摘要
Background: The objective of this study is to evaluate the effect of protein-rich mucuna product (PRMP) on lipid parameters of hyperlipidemic rats. Methods: Hyperlipidemia was induced in male rats for 3 weeks through high-fat diet. After induction, 30 hyperlipidemic rats were divided into five groups of six rats: control group (CG) received casein and four groups received PRMP as protein source at different proportions: 8.2, 16.4, 24.6, and 32.8 % corresponding, respectively, to 25, 50, 75, and 100 % substitution of casein in the diet for 3 weeks. Lipid and oxidative stress parameters of rats were assessed. Results: There were no significant differences in food intake and body weight loss among the experimental groups. The concentrations of the serum low-density lipoprotein cholesterol, total cholesterol, and triglycerides were lower in groups fed on PRMP 50, 75, and 100 % than in the CG group (p < 0.05). Histological analysis of the liver revealed that animals fed on PRMP diets presented a lower level of steatosis than the CG group. The most significant reduction of lipid parameters was obtained when PRMP was used as unique source of protein (PRMP 100 %). PRMP also influenced oxidative stress parameters as evidenced by a decrease in malondialdehyde and an increase in catalase and superoxide dismutase. Conclusions: These findings demonstrated that PRMP exerts hypolipidemic effect; it has a metabolic effect on endogenous cholesterol metabolism and a protector effect on the development of hepatic steatosis. Our results also suggest that PRMP could manage metabolic diseases associated with oxidative stress. © 2016, The Author(s).
引用
收藏
相关论文
共 50 条
  • [41] LIPID-LOWERING DRUGS AND VIOLENCE
    HORROBIN, DF
    BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 : 882 - 883
  • [42] Rhabdomyolysis and lipid-lowering drugs
    Tenenbaum, A
    Fisman, EZ
    Motro, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12): : 1448 - 1448
  • [43] Lipid-lowering drugs and homocysteine
    Landray, MJ
    Townend, JN
    Martin, S
    Martin, U
    Wheeler, DC
    LANCET, 1999, 353 (9168): : 1974 - 1975
  • [44] Carcinogenicity of lipid-lowering drugs
    Newman, TB
    Hulley, SB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (01): : 55 - 60
  • [46] Inflammation and lipid-lowering treatment
    Ballantyne C.M.
    Abe Y.
    Current Cardiology Reports, 1999, 1 (3) : 251 - 255
  • [47] Discontinuing lipid-lowering agents
    Davis, George F.
    JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (03) : 619 - 619
  • [48] Lipid-lowering trials in diabetes
    Armitage, J
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 1999, 1 (0M) : M13 - M17
  • [49] Lipid-Lowering Drugs and Cataract
    Bezin, Julien
    Mansiaux, Yohann
    Pariente, Antoine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 555 - 555
  • [50] SAFETY OF LIPID-LOWERING TREATMENT
    Elikir, G.
    Hesse, E.
    Sanchez, R.
    Baglivo, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 195 - 196